Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.

Lévesque E, Labriet A, Hovington H, Allain ÉP, Melo-Garcia L, Rouleau M, Brisson H, Turcotte V, Caron P, Villeneuve L, Leclercq M, Droit A, Audet-Walsh E, Simonyan D, Fradet Y, Lacombe L, Guillemette C.

Br J Cancer. 2020 Feb 12. doi: 10.1038/s41416-020-0749-2. [Epub ahead of print]

PMID:
32047296
2.

Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation.

Vaillancourt J, Turcotte V, Caron P, Villeneuve L, Lacombe L, Pouliot F, Lévesque É, Guillemette C.

Drug Metab Dispos. 2020 Feb;48(2):75-84. doi: 10.1124/dmd.119.088229. Epub 2019 Nov 14.

PMID:
31727674
3.

Inactivation of Prostaglandin E2 as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia.

Allain EP, Rouleau M, Le T, Vanura K, Villeneuve L, Caron P, Turcotte V, Lévesque E, Guillemette C.

Front Oncol. 2019 Jul 4;9:606. doi: 10.3389/fonc.2019.00606. eCollection 2019.

4.

Association Between Cerebellum Volumes and Cognitive Functioning.

Potvin O, Turcotte V, Duchesne S; CIMA-Q group.

Alzheimer Dis Assoc Disord. 2019 Jun 7. doi: 10.1097/WAD.0000000000000327. [Epub ahead of print] No abstract available.

PMID:
31180917
5.

Feasibility of a tapering opioids prescription program for trauma patients at high risk of chronic consumption (TOPP-trauma): protocol for a pilot randomized controlled trial.

Bérubé M, Deslauriers V, Leduc S, Turcotte V, Dupuis S, Roy I, Clairoux S, Panic S, Nolet M.

Pilot Feasibility Stud. 2019 May 10;5:67. doi: 10.1186/s40814-019-0444-3. eCollection 2019.

6.

A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer.

Lévesque E, Caron P, Lacombe L, Turcotte V, Simonyan D, Fradet Y, Aprikian A, Saad F, Carmel M, Chevalier S, Guillemette C.

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):701-706. doi: 10.1158/1055-9965.EPI-18-1002. Epub 2019 Feb 7.

PMID:
30733309
7.

An LC-MS/MS method for quantification of abiraterone, its active metabolites D(4)-abiraterone (D4A) and 5α-abiraterone, and their inactive glucuronide derivatives.

Caron P, Turcotte V, Lévesque E, Guillemette C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 1;1104:249-255. doi: 10.1016/j.jchromb.2018.12.003. Epub 2018 Dec 4.

PMID:
30537624
8.

Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A Post Hoc Analysis of the PR.7 Trial.

Toren P, Hoffman A, Ding K, Joncas FH, Turcotte V, Caron P, Pouliot F, Fradet Y, Lévesque É, Guillemette C, Klotz L.

Clin Cancer Res. 2018 Nov 1;24(21):5305-5312. doi: 10.1158/1078-0432.CCR-18-1187. Epub 2018 Jul 18.

9.

Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients.

Allain EP, Venzl K, Caron P, Turcotte V, Simonyan D, Gruber M, Le T, Lévesque E, Guillemette C, Vanura K.

Ann Hematol. 2018 Sep;97(9):1649-1661. doi: 10.1007/s00277-018-3356-z. Epub 2018 May 21.

10.

Normative data for the Clock Drawing Test for French-Quebec mid- and older aged healthy adults.

Turcotte V, Gagnon ME, Joubert S, Rouleau I, Gagnon JF, Escudier F, Koski L, Potvin O, Macoir J, Hudon C.

Clin Neuropsychol. 2018 Jan-Dec;32(sup1):91-101. doi: 10.1080/13854046.2018.1473495. Epub 2018 May 9.

PMID:
29742962
11.

Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery.

Audet-Delage Y, Grégoire J, Caron P, Turcotte V, Plante M, Ayotte P, Simonyan D, Villeneuve L, Guillemette C.

J Steroid Biochem Mol Biol. 2018 Apr;178:45-54. doi: 10.1016/j.jsbmb.2017.10.021. Epub 2017 Oct 29.

PMID:
29092787
12.

Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells.

Fortin S, Charest-Morin X, Turcotte V, Lauvaux C, Lacroix J, Côté MF, Gobeil S, C-Gaudreault R.

J Med Chem. 2017 Jun 22;60(12):4963-4982. doi: 10.1021/acs.jmedchem.7b00343. Epub 2017 Jun 1.

PMID:
28535350
13.

Peroxisome proliferator-activated receptor γ activation favours selective subcutaneous lipid deposition by coordinately regulating lipoprotein lipase modulators, fatty acid transporters and lipogenic enzymes.

Blanchard PG, Turcotte V, Côté M, Gélinas Y, Nilsson S, Olivecrona G, Deshaies Y, Festuccia WT.

Acta Physiol (Oxf). 2016 Jul;217(3):227-39. doi: 10.1111/apha.12665. Epub 2016 Mar 12.

PMID:
26918671
14.
15.

Palliative care costs in Canada: A descriptive comparison of studies of urban and rural patients near end of life.

Dumont S, Jacobs P, Turcotte V, Turcotte S, Johnston G.

Palliat Med. 2015 Dec;29(10):908-17. doi: 10.1177/0269216315583620. Epub 2015 Jun 3.

PMID:
26040484
16.

Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk.

Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Wood SN, Falk RT, Parisi D, Guillemette C, Caron P, Turcotte V, Habel LA, Isaacs CJ, Riboli E, Weiderpass E, Cook MB.

J Clin Oncol. 2015 Jun 20;33(18):2041-50. doi: 10.1200/JCO.2014.59.1602. Epub 2015 May 11.

17.

Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues.

Margaillan G, Rouleau M, Fallon JK, Caron P, Villeneuve L, Turcotte V, Smith PC, Joy MS, Guillemette C.

Drug Metab Dispos. 2015 Apr;43(4):611-9. doi: 10.1124/dmd.114.062877. Epub 2015 Feb 3.

18.

Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a case-control analysis.

Cook MB, Wood SN, Cash BD, Young P, Acosta RD, Falk RT, Pfeiffer RM, Hu N, Su H, Wang L, Wang C, Gherman B, Giffen C, Dykes C, Turcotte V, Caron P, Guillemette C, Dawsey SM, Abnet CC, Hyland PL, Taylor PR.

Clin Gastroenterol Hepatol. 2015 Apr;13(4):673-82. doi: 10.1016/j.cgh.2014.08.027. Epub 2014 Aug 24.

19.

Distribution and sharing of palliative care costs in rural areas of Canada.

Dumont S, Jacobs P, Turcotte V, Turcotte S, Johnston G.

J Palliat Care. 2014 Summer;30(2):90-8.

PMID:
25058986
20.

The use of palliative sedation: A comparison of attitudes of French-speaking physicians from Quebec and Switzerland.

Dumont S, Blondeau D, Turcotte V, Borasio GD, Currat T, Foley RA, Beauverd M.

Palliat Support Care. 2015 Aug;13(4):839-47. doi: 10.1017/S1478951514000364. Epub 2014 May 14.

PMID:
24825473
21.

Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.

Lévesque É, Laverdière I, Lacombe L, Caron P, Rouleau M, Turcotte V, Têtu B, Fradet Y, Guillemette C.

Clin Cancer Res. 2014 Feb 1;20(3):576-84. doi: 10.1158/1078-0432.CCR-13-1100. Epub 2013 Nov 25.

22.

Determining the mode of action involved in the antimicrobial activity of synthetic peptides: a solid-state NMR and FTIR study.

Lorin A, Noël M, Provencher MÈ, Turcotte V, Cardinal S, Lagüe P, Voyer N, Auger M.

Biophys J. 2012 Oct 3;103(7):1470-9. doi: 10.1016/j.bpj.2012.08.055. Epub 2012 Oct 2.

23.

Synthesis, biological evaluation, and structure-activity relationships of novel substituted N-phenyl ureidobenzenesulfonate derivatives blocking cell cycle progression in S-phase and inducing DNA double-strand breaks.

Turcotte V, Fortin S, Vevey F, Coulombe Y, Lacroix J, Côté MF, Masson JY, C-Gaudreault R.

J Med Chem. 2012 Jul 12;55(13):6194-208. doi: 10.1021/jm3006492. Epub 2012 Jun 21.

24.

Major involvement of mTOR in the PPARγ-induced stimulation of adipose tissue lipid uptake and fat accretion.

Blanchard PG, Festuccia WT, Houde VP, St-Pierre P, Brûlé S, Turcotte V, Côté M, Bellmann K, Marette A, Deshaies Y.

J Lipid Res. 2012 Jun;53(6):1117-25. doi: 10.1194/jlr.M021485. Epub 2012 Mar 30.

25.

Synthesis and properties of monofluorinated dimyristoylphosphatidylcholine derivatives: potential fluorinated probes for the study of membrane topology.

Guimond-Tremblay J, Gagnon MC, Pineault-Maltais JA, Turcotte V, Auger M, Paquin JF.

Org Biomol Chem. 2012 Feb 14;10(6):1145-8. doi: 10.1039/c2ob06570c. Epub 2011 Dec 19.

PMID:
22179779
26.

Evaluating the economic loss of caregiving for palliative care patients.

Jacobs P, Dumont S, Turcotte V, Anderson D.

J Palliat Care. 2011 Autumn;27(3):210-5.

PMID:
21957798
27.

Revisiting peptide amphiphilicity for membrane pore formation.

Lorin A, Noël M, Provencher MÈ, Turcotte V, Masson C, Cardinal S, Lagüe P, Voyer N, Auger M.

Biochemistry. 2011 Nov 1;50(43):9409-20. doi: 10.1021/bi201335t. Epub 2011 Oct 6.

PMID:
21942823
28.

Measurement challenges of informal caregiving: a novel measurement method applied to a cohort of palliative care patients.

Dumont S, Jacobs P, Turcotte V, Anderson D, Harel F.

Soc Sci Med. 2010 Nov;71(10):1890-5. doi: 10.1016/j.socscimed.2010.08.003. Epub 2010 Sep 15.

PMID:
20884103
29.

The trajectory of palliative care costs over the last 5 months of life: a Canadian longitudinal study.

Dumont S, Jacobs P, Turcotte V, Anderson D, Harel F.

Palliat Med. 2010 Sep;24(6):630-40. doi: 10.1177/0269216310368453. Epub 2010 May 25.

PMID:
20501512
30.

Costs associated with resource utilization during the palliative phase of care: a Canadian perspective.

Dumont S, Jacobs P, Fassbender K, Anderson D, Turcotte V, Harel F.

Palliat Med. 2009 Dec;23(8):708-17. doi: 10.1177/0269216309346546. Epub 2009 Oct 16.

PMID:
19837702
31.

Crushing virtual cigarettes reduces tobacco addiction and treatment discontinuation.

Girard B, Turcotte V, Bouchard S, Girard B.

Cyberpsychol Behav. 2009 Oct;12(5):477-83. doi: 10.1089/cpb.2009.0118.

PMID:
19817561
32.

Solvent removal of beryllium from surfaces of equipment made of beryllium copper.

Dufresne A, Turcotte V, Golshahi H, Viau S, Perrault G, Dion C.

Ann Occup Hyg. 2009 Jun;53(4):353-62. doi: 10.1093/annhyg/mep007. Epub 2009 Mar 2.

PMID:
19254960
33.

The PPARgamma agonist rosiglitazone enhances rat brown adipose tissue lipogenesis from glucose without altering glucose uptake.

Festuccia WT, Blanchard PG, Turcotte V, Laplante M, Sariahmetoglu M, Brindley DN, Richard D, Deshaies Y.

Am J Physiol Regul Integr Comp Physiol. 2009 May;296(5):R1327-35. doi: 10.1152/ajpregu.91012.2008. Epub 2009 Feb 11.

34.

Depot-specific effects of the PPARgamma agonist rosiglitazone on adipose tissue glucose uptake and metabolism.

Festuccia WT, Blanchard PG, Turcotte V, Laplante M, Sariahmetoglu M, Brindley DN, Deshaies Y.

J Lipid Res. 2009 Jun;50(6):1185-94. doi: 10.1194/jlr.M800620-JLR200. Epub 2009 Feb 5.

35.

Comparative morbidity in cesarean section.

TURCOTTE VJ, JARVIS HF.

J Mich State Med Soc. 1948 Mar;47(3):294-6. No abstract available.

PMID:
18911197
36.

Extrauterine pregnancy.

DINDIA AH, TURCOTTE VJ.

Am J Obstet Gynecol. 1946 Aug;52:321-4. No abstract available.

PMID:
20993780
37.

Rupture of the uterus.

DINDIA AH, TURCOTTE VJ.

Ohio State Med J. 1946 Jul;42:736-8. No abstract available.

PMID:
20988869

Supplemental Content

Loading ...
Support Center